![]() |
市場調查報告書
商品編碼
1887118
桌上型超音波設備市場規模、佔有率、成長及全球產業分析:依類型、應用和地區劃分的洞察,以及2024-2032年預測Table-top Ultrasound Equipment Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032 |
||||||
2024年,全球桌上型超音波設備市場維持成長勢頭,達到66.3億美元。預計該市場將穩定成長,到2025年達到69.5億美元,到2032年達到96億美元,2025年至2032年的複合年增長率(CAGR)為4.7%。這一增長主要得益於對先進診斷成像需求的不斷增長、慢性病患病率的上升以及超音波系統技術的不斷創新。 2024年,亞太地區以43.74%的市佔率佔主導地位,這主要得益於其龐大的人口基數、不斷完善的醫療基礎設施以及快速老化的人口結構。
主要市場驅動因子
該市場的主要推動力是全球對診斷影像的需求不斷增長,而這又源於急慢性疾病盛行率的上升。心血管疾病、癌症、泌尿系統疾病和婦科併發症等疾病正在推動全球診斷率的提高。根據美國癌症協會(2024 年)預測,2024 年新增癌症病例約 200 萬例,這將顯著增加對先進影像工具的需求。
亞太地區,尤其是中國,擁有龐大的病患群體,需要診斷服務。根據中國政府 2024 年的報告,中國 60 歲以上老年人口達 2.97 億人。隨著人口老化,超音波檢查的數量不斷增加,從而推動了對可靠、高品質診斷的需求。桌上型超音波系統以其卓越的影像清晰度和在臨床應用中的多功能性而聞名,正成為醫院和診斷中心的首選。
同時,西門子醫療、通用電氣醫療、飛利浦醫療和佳能醫療系統等主要市場參與者正大力投資研發,以推出能夠提高影像精度的創新產品。這種穩定的技術進步正在加速全球醫療系統對這些產品的採用。
市場限制因子
桌上型超音波系統成本高是市場擴張的主要障礙。根據富士軟片Sonosite發布的2025年報告,新系統的價格將在5萬美元至15萬美元之間。這限制了其普及,尤其是在醫療預算有限的新興國家。此外,快速成長的二手超音波系統市場也對新設備製造商構成了競爭挑戰。二手系統的售價低至每台5000美元至15000美元。
市場機會
隨著超音波影像在醫療保健領域的應用不斷擴展,市場機會也日益顯著。桌上型超音波系統在心臟科、婦科、腫瘤學、急診醫學和內科等領域的應用,使其成為重要的診斷工具。此外,床邊超音波(POCUS)也正迅速普及。根據GE醫療(2023)報告,POCUS在診斷腹主動脈瘤方面具有98-100%的特異性,使其成為急診診斷的關鍵工具。
3D和4D超音波技術的日益普及,以及人工智慧(AI)在成像平台中整合度的不斷提高,持續為系統升級和新產品發布創造機會。
市場趨勢
影響市場的一個顯著趨勢是轉向技術先進的成像設備。高階機型提供卓越的解析度、基於人工智慧的影像增強、遠距醫療功能和先進的後處理功能。 2024年,富士軟片推出了ALOKA ARIETTA 850,標誌著業界正向更聰明的診斷系統轉型。此外,三星於2024年推出的HERA Z20系統進一步鞏固了該公司在婦產科影像領域的地位。
2024年,3D超音波細分市場引領市場,這主要得益於心臟病學和婦科領域對精細可視化影像日益增長的需求。在婦科領域,由於異位妊娠和骨盆腔癌等疾病的高發生率,3D超音波的應用持續成長。
依終端用戶劃分,由於等待時間縮短、就診更便捷以及提供專業的影像服務,診斷影像中心預計將顯著增長。預計到 2023 年,光是美國就將擁有 19,000 個影像中心,以支撐較高的設備利用率。
亞太地區
預計到 2024 年,該地區市場規模將達到 29 億美元。中國、日本和印度憑藉其高疾病盛行率、龐大的患者群體以及快速的技術應用,將繼續保持領先地位。
北美
強勁的醫療保健支出、有利的報銷機制以及持續的產品創新(包括 GE 醫療於 2024 年收購 AI)正在推動該地區的成長。
歐洲
高人均醫療保健支出和診斷技術的早期應用正在推動對桌上型超音波系統的持續高需求。
The global table-top ultrasound equipment market continued its upward trajectory in 2024, reaching a valuation of USD 6.63 billion. The market is projected to grow steadily to USD 6.95 billion in 2025 and further to USD 9.60 billion by 2032, reflecting a CAGR of 4.7% from 2025 to 2032. This growth is driven by the increasing need for advanced diagnostic imaging, rising chronic disease prevalence, and expanding technological innovations in ultrasound systems. In 2024, Asia Pacific dominated the market with a share of 43.74%, driven by its large population, expanding healthcare infrastructure, and rapidly aging demographic.
Key Market Drivers
The market is primarily driven by the increasing prevalence of acute and chronic disorders, which has elevated the global demand for diagnostic imaging. Conditions such as cardiovascular diseases, cancer, urological disorders, and gynecological complications are prompting higher diagnosis rates worldwide. According to the American Cancer Society (2024), approximately 2.0 million new cancer cases were expected in the U.S. in 2024, significantly raising the need for advanced imaging tools.
Asia Pacific, particularly China, shows a substantial patient base requiring diagnostic services, with 297 million adults aged 60 and above as reported by the Government of China in 2024. The aging demographic results in escalating ultrasound scans and an increasing need for reliable, high-quality diagnosis. Table-top ultrasound systems, known for superior image clarity and versatile use across clinical applications, are becoming the preferred choice for hospitals and diagnostic centers.
Simultaneously, leading market players such as Siemens Healthineers AG, GE Healthcare, Philips Healthcare, and Canon Medical Systems are investing heavily in R&D to launch innovative products that deliver enhanced imaging accuracy. This consistent technological progress is accelerating adoption across global healthcare systems.
Market Restraints
The major barrier to market expansion is the high cost associated with table-top ultrasound equipment. New systems can cost between USD 50,000 and USD 150,000, as reported by FUJIFILM Sonosite in 2025. This restricts adoption mainly in emerging economies, where healthcare budgets remain constrained. Additionally, the rapid expansion of the refurbished ultrasound equipment market-priced as low as USD 5,000 to USD 15,000 per system-presents a competitive challenge for manufacturers of new devices.
Market Opportunities
The market presents significant opportunities due to the expanding medical applications of ultrasound imaging. The integration of table-top ultrasound systems in cardiology, gynecology, oncology, emergency medicine, and internal medicine has positioned these devices as essential diagnostic tools. Furthermore, point-of-care ultrasound (POCUS) is gaining widespread adoption. According to GE Healthcare (2023), POCUS demonstrated 98-100% specificity in diagnosing abdominal aortic aneurysms, making it a vital tool in emergency diagnostics.
The increasing adoption of 3D and 4D ultrasound technologies and the growing integration of artificial intelligence (AI) within imaging platforms continue to create opportunities for system upgrades and new product launches.
Market Trends
A prominent trend shaping the market is the shift toward technologically advanced imaging equipment. High-end models now offer superior resolution, AI-based image enhancement, telemedicine readiness, and advanced post-processing capabilities. In 2024, FUJIFILM introduced the ALOKA ARIETTA 850, demonstrating the industry's pivot toward smarter diagnostic systems. Furthermore, Samsung's HERA Z20 system, launched in 2024, strengthened the company's position in the OB/GYN imaging field.
In 2024, the 3D ultrasound segment led the market due to rising demand for detailed visualization in cardiology and gynecology. In gynecological applications, the prevalence of conditions such as ectopic pregnancies and pelvic cancers continues to drive adoption.
Among end-users, diagnostic imaging centers are projected to grow significantly due to shorter wait times, accessibility, and specialized imaging services. The U.S. alone had 19,000 imaging centers in 2023, supporting high device utilization.
Asia Pacific
The region generated USD 2.90 billion in 2024, maintaining dominance due to high disease prevalence, large patient volume, and rapid technological adoption in China, Japan, and India.
North America
Strong healthcare spending, favorable reimbursement systems, and continuous product innovations-such as GE Healthcare's 2024 AI acquisition-propel regional growth.
Europe
High per capita healthcare expenditure and early adoption of diagnostic technologies sustain substantial demand for table-top ultrasound systems.
Conclusion
The table-top ultrasound equipment market will continue to expand from USD 6.63 billion in 2024 to USD 9.60 billion by 2032, supported by rising chronic disease burden, diagnostic advancements, and technological innovation. Asia Pacific remains the global growth engine, while North America and Europe continue to adopt new-generation systems at a strong pace.
Segmentation By Type
By Application
By End-user
By Region